H.R. 4083 - Non-Prescription Drug Modernization Act of 2007
Medicine.
- Sponsor:
- Henry Waxman
- Summary:
- To amend the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes. (by CRS)
- Status:
- The bill has been introduced.
There have been no votes on this bill.
Non-Prescription Drug Modernization Act of 2007
H.R. 4083 — 110th Congress (2007–2008)
- Summary
- To amend the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes. (by CRS)
- Learn More
- At OpenCongress
- Title
- To amend the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes.
- Other Titles
- Non-Prescription Drug Modernization Act of 2007
- Sponsor
- Henry Waxman
- Co-Sponsors
- Subjects
- Medicine
- Administrative procedure
- Business
- Congress
- Congressional reporting requirements
- Consumer education
- Consumers
- Deceptive advertising
- Department of Health and Human Services
- Drug adulteration
- Drug industry
- Drugs
- Executive departments
- Food and Drug Administration (FDA)
- Labeling
- Law
- Medical care
- Related Bills
- Major Actions
Introduced 11/06/2007 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 11/06/2007 11/06/2007 Referred to the House Committee on Energy and Commerce. Number Sponsor Date Offered Status
Includes reported contributions to congressional campaigns of House members in office during the 110th U.S. Congress, from interest groups invested in the vote according to MapLight, January 1, 2007 – December 31, 2008.
Contributions data source: OpenSecrets.org
Contributions data source: OpenSecrets.org
